We are live on ! Find out more
CG

Cutler Group Portfolio holdings

AUM $307M
1-Year Est. Return 45.11%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.49%
10 Year Est. Return
AUM
$1.08B
AUM Growth
+$113M
Cap. Flow
+$218M
Cap. Flow %
20.27%
Top 10 Hldgs %
24.73%
Holding
5,191
New
1,217
Increased
1,324
Reduced
1,416
Closed
1,020

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.99%
2 Technology 11.55%
3 Communication Services 10.48%
4 Financials 4.57%
5 Industrials 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITCI
2301
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18K ﹤0.01%
7,100
+5,000
+238% +$64.1K
RVNC
2302
DELISTED
Revance Therapeutics, Inc.
RVNC
$18K ﹤0.01%
1,400
HOLI
2303
PUT
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$18K ﹤0.01%
10,500
+6,300
+150% +$122K
MRNS
2304
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18K ﹤0.01%
2,500
ICPT
2305
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$18K ﹤0.01%
1,400
-12,800
-90% -$1.15M
HEXO
2306
CALL
DELISTED
HEXO Corp. Common Shares
HEXO
$18K ﹤0.01%
+891
New +$330K
PLAN
2307
CALL
DELISTED
Anaplan, Inc.
PLAN
$18K ﹤0.01%
+4,900
New +$203K
ZNGA
2308
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$18K ﹤0.01%
+3,000
New +$17.7K
ABR icon
2309
CALL
Arbor Realty Trust
ABR
$977M
$17K ﹤0.01%
6,500
+5,500
+550% +$71.5K
ACHC icon
2310
Acadia Healthcare
ACHC
$2.52B
$17K ﹤0.01%
500
-200
-29% -$6.47K
APA icon
2311
PUT
APA Corp
APA
$13B
$17K ﹤0.01%
12,400
+1,900
+18% +$59.1K
BMRN icon
2312
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
$17K ﹤0.01%
7,500
+4,500
+150% +$385K
CALM icon
2313
PUT
Cal-Maine
CALM
$4.43B
$17K ﹤0.01%
18,600
+15,000
+417% +$617K
CIEN icon
2314
PUT
Ciena
CIEN
$46.8B
$17K ﹤0.01%
+4,700
New +$181K
DIN icon
2315
PUT
Dine Brands
DIN
$462M
$17K ﹤0.01%
3,700
-800
-18% -$73K
EDZ icon
2316
PUT
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$21.5M
$17K ﹤0.01%
300
-2,000
-87% -$903K
ESPR
2317
PUT
DELISTED
Esperion Therapeutics
ESPR
$17K ﹤0.01%
1,100
EXEL icon
2318
PUT
Exelixis
EXEL
$13.9B
$17K ﹤0.01%
28,500
+26,000
+1,040% +$545K
FAZ icon
2319
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$85.8M
$17K ﹤0.01%
1,573
+1,062
+208% +$3.53M
GEL icon
2320
PUT
Genesis Energy
GEL
$1.82B
$17K ﹤0.01%
+12,100
New +$270K
GKOS icon
2321
PUT
Glaukos
GKOS
$9.49B
$17K ﹤0.01%
+6,500
New +$466K
HBI
2322
PUT
DELISTED
Hanesbrands
HBI
$17K ﹤0.01%
7,800
+2,800
+56% +$48.2K
BRSL
2323
PUT
Brightstar Lottery PLC
BRSL
$1.9B
$17K ﹤0.01%
41,300
+33,700
+443% +$458K
IWB icon
2324
CALL
iShares Russell 1000 ETF
IWB
$47.1B
$17K ﹤0.01%
1,100
-300
-21% -$48K
MCY icon
2325
CALL
Mercury Insurance
MCY
$6B
$17K ﹤0.01%
+6,500
New +$363K

Similar funds

Cutler Group's Q2 2019 Portfolio in Review

As of Q2 2019, Cutler Group held 5,191 positions worth $1.08B, up 12% from $964M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cutler Group deployed $218M of net new capital in Q2 2019, opening 1,217 new positions and adding to 1,324 existing holdings. Its largest new stake was Invesco QQQ Trust: 145,813 shares worth $27.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.4M trimmed.

  • Cutler Group's largest Q2 2019 buy was Invesco QQQ Trust: 145,813 shares worth $27.2M.
  • Cutler Group added most to Amazon in Q2 2019, an estimated $30.5M increase.
  • Cutler Group's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $13.4M.
  • Cutler Group fully exited Xtrackers Harvest CSI 300 China A-Shares ETF in Q2 2019, selling an estimated $8.47M.
  • Cutler Group's ten largest holdings make up 25% of its $1.08B portfolio in Q2 2019.
  • Cutler Group opened 1,217 new positions and closed 1,020 in Q2 2019.
  • Cutler Group's portfolio value rose 12% quarter-over-quarter to $1.08B.

Based on Cutler Group's 13F filing for Q2 2019, filed 9 Aug 2019.